[go: up one dir, main page]

CY1121886T1 - Πρωτεϊνη απαλλαγμενη απο φαινυλαλανινη για την αγωγη της pku - Google Patents

Πρωτεϊνη απαλλαγμενη απο φαινυλαλανινη για την αγωγη της pku

Info

Publication number
CY1121886T1
CY1121886T1 CY20191100853T CY191100853T CY1121886T1 CY 1121886 T1 CY1121886 T1 CY 1121886T1 CY 20191100853 T CY20191100853 T CY 20191100853T CY 191100853 T CY191100853 T CY 191100853T CY 1121886 T1 CY1121886 T1 CY 1121886T1
Authority
CY
Cyprus
Prior art keywords
protein
phenylalanine
pku
treatment
dietary
Prior art date
Application number
CY20191100853T
Other languages
English (en)
Inventor
Bernhard Hoffmann
Yvonne MÜCKE
Stefan RASCHE
Natalia JABLONKA
Stefan Schillberg
Original Assignee
Metax Institut Für Diätetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Institut Für Diätetik Gmbh filed Critical Metax Institut Für Diätetik Gmbh
Publication of CY1121886T1 publication Critical patent/CY1121886T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Soy Sauces And Products Related Thereto (AREA)

Abstract

Παρέχεται μία ανασυνδυασμένη διαιτητική πρωτεΐνη που είναι απαλλαγμένη από φαινυλαλανίνη και είναι μία διαιτητική πρωτεΐνη με υψηλή βιολογική αξία. Επιπλέον, παρέχονται ένας φορέας που κωδικοποιεί την εν λόγω διαιτητική πρωτεΐνη, μικροοργανισμοί που εκφράζουν την εν λόγω πρωτεΐνη, μία μέθοδος για την παραγωγή της εν λόγω πρωτεΐνης και μία διαιτητική σύνθεση που περιλαμβάνει την εν λόγω πρωτεΐνη που σε μία πραγματοποίηση είναι για χρήση ως θεραπευτικό μέσο και/ή τροφή για ειδικούς ιατρικούς σκοπούς σε ασθενείς με συσσώρευση φαινυλαλανίνης στο σώμα.
CY20191100853T 2016-09-01 2019-08-08 Πρωτεϊνη απαλλαγμενη απο φαινυλαλανινη για την αγωγη της pku CY1121886T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (en) 2016-09-01 2016-09-01 Phenylalanine-free protein for the treatment of pku

Publications (1)

Publication Number Publication Date
CY1121886T1 true CY1121886T1 (el) 2020-10-14

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100853T CY1121886T1 (el) 2016-09-01 2019-08-08 Πρωτεϊνη απαλλαγμενη απο φαινυλαλανινη για την αγωγη της pku

Country Status (28)

Country Link
US (1) US10640538B2 (el)
EP (1) EP3290436B1 (el)
JP (1) JP6954676B2 (el)
CN (1) CN109661401B (el)
AU (1) AU2017317652B2 (el)
BR (1) BR112019004270A2 (el)
CA (1) CA3033271C (el)
CY (1) CY1121886T1 (el)
DK (1) DK3290436T3 (el)
ES (1) ES2742175T3 (el)
HR (1) HRP20191406T1 (el)
HU (1) HUE044665T2 (el)
IL (1) IL265015B2 (el)
LT (1) LT3290436T (el)
MA (1) MA43352B1 (el)
MD (1) MD3290436T2 (el)
ME (1) ME03510B (el)
MX (1) MX378970B (el)
NZ (1) NZ750498A (el)
PL (1) PL3290436T3 (el)
PT (1) PT3290436T (el)
RU (1) RU2764796C2 (el)
SA (1) SA519401175B1 (el)
SI (1) SI3290436T1 (el)
SM (1) SMT201900464T1 (el)
UA (1) UA124630C2 (el)
WO (1) WO2018041920A1 (el)
ZA (1) ZA201901505B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用
CN110746494B (zh) * 2019-09-27 2021-07-20 深圳市诺维健生物技术有限责任公司 一组特殊膳食蛋白质

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
WO1996017064A1 (en) 1994-12-02 1996-06-06 Indiana University Foundation Phenylalanine free proteins
EP1092769B1 (de) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden
KR20030085112A (ko) * 2000-12-07 2003-11-03 디에스엠 아이피 어셋츠 비.브이. 카르복시 말단 프롤린 잔기를 갖는 펩티드가 풍부한단백질 가수분해물
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
MX2009011523A (es) 2007-04-27 2009-11-09 Dow Global Technologies Inc Metodo para clasificar rapidamente huespedes microbianos para identificar ciertas cepas con rendimiento y/o calidad mejorados en la expresion de proteinas heterologas.
US20100316623A1 (en) * 2009-04-23 2010-12-16 Andrew Turner Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
MX2014011614A (es) 2012-03-26 2015-04-08 Pronutria Inc Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos.
CN104936466A (zh) 2012-11-20 2015-09-23 普罗努塔利亚公司 工程化的分泌蛋白质和方法
PL3197472T3 (pl) 2014-09-22 2021-12-27 Tanea Medical Ab Rekombinowane białka wolne od phe do stosowania w leczeniu fenyloketonurii

Also Published As

Publication number Publication date
EP3290436A1 (en) 2018-03-07
RU2019109142A (ru) 2020-10-01
RU2019109142A3 (el) 2021-01-27
BR112019004270A2 (pt) 2019-06-04
CA3033271C (en) 2024-04-02
US20190202872A1 (en) 2019-07-04
IL265015A (el) 2019-04-30
AU2017317652B2 (en) 2020-11-19
WO2018041920A1 (en) 2018-03-08
EP3290436B1 (en) 2019-06-05
SI3290436T1 (sl) 2019-11-29
IL265015B1 (en) 2024-04-01
SA519401175B1 (ar) 2022-01-08
CN109661401A (zh) 2019-04-19
MX2019002422A (es) 2019-07-04
JP6954676B2 (ja) 2021-10-27
ZA201901505B (en) 2020-08-26
JP2019533988A (ja) 2019-11-28
MX378970B (es) 2025-03-10
IL265015B2 (en) 2024-08-01
CA3033271A1 (en) 2018-03-08
HRP20191406T1 (hr) 2019-11-15
SMT201900464T1 (it) 2020-01-14
MA43352B1 (fr) 2019-08-30
LT3290436T (lt) 2019-10-10
ME03510B (me) 2020-04-20
AU2017317652A1 (en) 2019-02-28
DK3290436T3 (da) 2019-08-19
RU2764796C2 (ru) 2022-01-21
UA124630C2 (uk) 2021-10-20
US10640538B2 (en) 2020-05-05
PT3290436T (pt) 2019-08-30
MA43352A (fr) 2018-03-07
CN109661401B (zh) 2023-12-19
HUE044665T2 (hu) 2019-11-28
ES2742175T3 (es) 2020-02-13
PL3290436T3 (pl) 2020-01-31
NZ750498A (en) 2023-01-27
MD3290436T2 (ro) 2019-10-31

Similar Documents

Publication Publication Date Title
CY1123746T1 (el) Ανθρωποποιημενα tau αντισωματα σε νοσο του alzheimer
CL2023000972A1 (es) Inhibidores de ras
CY1124955T1 (el) Pd-1 αντισωματα
MX2019001920A (es) Arn la terapia contra el cancer.
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
EA201890272A1 (ru) Axl-специфические конъюгаты антитело-лекарственное средство для лечения рака
CY1120288T1 (el) Συζευγματα αντισωματος-φαρμακου που περιεχουν duocarmycin για χρηση στη θεραπεια του καρκινου της ουροδοχου κυστης
EA201890006A1 (ru) Применение экзосом для лечения болезни
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
MX2022008868A (es) Tratamiento del cancer con tg02.
CY1122818T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου
CY1117712T1 (el) Adcs δουοκαρμυκινης για χρηση στη θεραπεια ενδομητριου καρκινου
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
CY1124596T1 (el) Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση
CY1123501T1 (el) Χρηση ρεσλιζουμαμπης για τη θεραπευτικη αντιμετωπιση μετριου εως σοβαρου ηωσινοφιλικου ασθματος
BR112021015036A2 (pt) Tratamento para câncer com imunoconjugados do anticorpo ror1
CY1124667T1 (el) Τροποποιημενο rna που κωδικοποιει πολυπεπτιδια vegf-a, φαρμακοτεχνικες μορφες, και χρησεις που σχετιζονται με αυτα
IL281605A (en) B*44 restricted peptides for use in immunotherapy against cancers and related methods
CY1122882T1 (el) Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
BR112018011177A2 (pt) conjugados de citarabina para terapia de câncer
CY1122923T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
CY1125271T1 (el) Φαρμακο για χρηση στη θεραπεια της ουρικης αρθριτιδας
CY1125014T1 (el) Υποκατεστημενα παραγωγα ξανθινης
MX2019003970A (es) Péptidos de arginasa inmunogénicos.
CY1125113T1 (el) Συνθεσεις και μεθοδοι για χρηση στην αγωγη της ομοκυστινουριας